Inventor · disambiguated record
Larry W. Kwak
Also filed as: KWAK LARRY · KWAK LARRY W
17 granted patents·11 pending applications·131 citations·filing 1993–2024
92Inventor score
Top patents by PatentIndex Score
28 records- 0189US6562347B1Chemokine-tumor antigen fusion proteins as cancer vaccinesUS HEALTH·Filed 1999·Granted May 13, 2003·90 cites·4 claims
- 0285US12215162B2BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereofHOPE CITY·Filed 2021·Granted Feb 4, 2025·1 cites·17 claims
- 0385US11981740B2BAFF-R antibodies and uses thereofHOPE CITY·Filed 2021·Granted May 14, 2024·1 cites·20 claims
- 0485US11136405B2BAFF-R antibodies and uses thereofHOPE CITY·Filed 2017·Granted Oct 5, 2021·3 cites·14 claims
- 0582US7754676B2Defensin-antigen fusion proteinsUS HEALTH·Filed 2001·Granted Jul 13, 2010·5 cites·34 claims
- 0681US7915040B2Defensin-antigen fusion proteinsUS HEALTH·Filed 2010·Granted Mar 29, 2011·2 cites·22 claims
- 0780US8551936B2Defensin-antigen fusion proteinsKWAK LARRY W·Filed 2011·Granted Oct 8, 2013·2 cites·20 claims
- 0877US11161908B2BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereofHOPE CITY·Filed 2017·Granted Nov 2, 2021·1 cites·25 claims
- 0977US8754030B2Defensin-antigen fusion proteinsUS HEALTH·Filed 2013·Granted Jun 17, 2014·1 cites·20 claims
- 1076US8084250B2Defensin-antigen fusion proteinsKWAK LARRY W·Filed 2011·Granted Dec 27, 2011·1 cites·30 claims
- 1176US2025092149A1Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 1275US2024287200A1Baff-r antibodies and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 1367US2014234362A1Defensin-antigen fusion proteinsUS HEALTH·Filed 2014·Application pending·0 cites
- 1463US7897152B2Viral chemokine-antigen fusion proteinsUS HEALTH·Filed 2001·Granted Mar 1, 2011·1 cites·32 claims
- 1562US8460675B2Viral chemokine-antigen fusion proteinsKWAK LARRY W·Filed 2012·Granted Jun 11, 2013·0 cites·15 claims
- 1658US2020199232A1Baff-r bispecific t-cell engager antibodyHOPE CITY·Filed 2019·Application pending·0 cites
- 1758US2023405109A1Nucleic acids, proteins, and vaccines of sars-cov-2HOPE CITY·Filed 2021·Application pending·0 cites
- 1857US2013224199A1Viral chemokine-antigen fusion proteinsDEPT OF HEALTH AND HUMAN SERVICES THE UNITED STATES OF AMERICA AS REPRESENTED AS BY THE SECRETARY·Filed 2013·Application pending·0 cites
- 1955US8318177B2Viral chemokine-antigen fusion proteinsKWAK LARRY W·Filed 2011·Granted Nov 27, 2012·0 cites·14 claims
- 2055US2003138452A1Chemokine-tumor antigen fusion proteins as cancer vaccinesFiled 2002·Application pending·0 cites
- 2153US11680102B2Anti-BAFF receptor antibodies and uses thereofYINNUOLAI BIOTECH LTD·Filed 2021·Granted Jun 20, 2023·0 cites·11 claims
- 2253US11597774B2Antibody variable domains and antibody constructsHOPE CITY·Filed 2018·Granted Mar 7, 2023·0 cites·16 claims
- 2352US6312718B1Vaccine for B-cell malignanciesBIOMIRA USA INC·Filed 1997·Granted Nov 6, 2001·11 cites·17 claims
- 2451US2022056132A1Baff-r bispecific t-cell engager antibodyHOPE CITY·Filed 2019·Application pending·0 cites
- 2549US2003021838A1Method of making therapeutic liposomal compositionsFiled 2001·Application pending·0 cites
- 2647US5861158AMethod and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donorUS HEALTH·Filed 1993·Granted Jan 19, 1999·12 cites·17 claims
- 2741US2014363456A1Tumor-specific gm-csf cytokine response as predictor of cancer vaccine effectivenessBIOVEST INT INC·Filed 2012·Application pending·0 cites
- 2840US2020354452A1Cars and bispecific antibodies for treatment of mantle cell lymphomaHOPE CITY·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →